Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105237569A reveals improved iodine-catalyzed synthesis. Delivers higher yield and simplified processing for reliable pharmaceutical intermediate supply chains.
Patent CN117820257B reveals a novel chiral hydrogenation method for pinaverium bromide intermediates, ensuring high purity and scalable supply chain reliability.
Patent CN1092660C details a novel cyclization and N-methylation route for Sildenafil, offering cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Novel methylation method enhances purity and yield for verapamil hydrochloride production offering significant supply chain and cost advantages for pharmaceutical manufacturers.
Novel acidified silica gel method for dabigatran intermediate. Reduces waste, improves purity, ensures supply chain stability for pharma manufacturing.
Novel patent CN119350189A details safer synthesis of chiral peptide intermediates ensuring high purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN101974604B details a novel ionic liquid biocatalysis route for paroxetine intermediates, offering high optical purity and reduced environmental impact for reliable supply chains.
Novel three-step synthesis of Paeoveitol overcomes natural isolation limits ensuring stable supply and cost efficiency for pharmaceutical intermediate manufacturing partners.
Novel solid-phase method enhances purity and yield. Reliable supply chain for complex peptide intermediates with optimized cyclization.
Novel chiral palladium catalysts for asymmetric synthesis offering high stability and selectivity for pharmaceutical intermediate manufacturing and cost reduction.
Patent CN104326960A details aqueous synthesis improving purity and yield. Offers supply chain reliability and cost reduction for peptide manufacturing partners globally.
Advanced solid-phase method improves purity and yield for bremelanotide manufacturing, offering cost reduction and supply chain stability for global partners.
Novel route for Scabellone A via CAN oxidation improves yield and scalability for API manufacturing supply chains.
Novel patent CN104478779A details high-purity Piracetam synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105439967A reveals metal-free triazole synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel synthetic route for Cephanolide B using Negishi coupling and Pd-catalysis. Offers cost reduction and scalable supply for pharma R&D teams.
Patent CN110054603A details a novel Pd-catalyzed C-H activation method for aryl C-glycosides, offering significant supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel phase transfer catalysis method for p-chlorophenylglycine improves yield and purity for pharmaceutical intermediates manufacturing supply chain efficiency and cost.
Patent CN106589015A reveals optimized Tribenoside synthesis reducing waste and improving purity. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN118546096A reveals a novel Pd-catalyzed route for chiral tetrahydropyridazines, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.